Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001362310-09-001447
Filing Date
2009-02-09
Accepted
2009-02-09 14:17:06
Documents
1
Group Members
NOVARTIS AGNOVARTIS PHARMA AG

Document Format Files

Seq Description Document Type Size
1 SC 13G/A c80630sc13gza.htm SC 13G/A 47482
  Complete submission text file 0001362310-09-001447.txt   49456
Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056
Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Subject) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79884 | Film No.: 09580788
SIC: 2834 Pharmaceutical Preparations